RAM
VKTX icon

Reflection Asset Management’s Viking Therapeutics VKTX Stock Holding History

Reflection Asset Management’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$11.7K Buy
+350
New +$12.4K 0.01% 452

Other funds holding VKTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Reflection Asset Management's VKTX Position: Q4 2025 in Review

Reflection Asset Management opened a new position in Viking Therapeutics (VKTX) in Q4 2025: 350 shares worth $11.7K. The stake represents 0.01% of the portfolio and ranks #452 among its holdings.

426 funds tracked by Wall St. Rank hold VKTX as of Q4 2025.

  • Reflection Asset Management held 350 shares of Viking Therapeutics worth $11.7K as of Q4 2025.
  • Viking Therapeutics was a new Reflection Asset Management position in Q4 2025.
  • Viking Therapeutics made up 0.01% of Reflection Asset Management's portfolio in Q4 2025, its #452 holding.
  • 426 funds tracked by Wall St. Rank held Viking Therapeutics as of Q4 2025.

Based on Reflection Asset Management's 13F filing for Q4 2025, filed 2 Mar 2026.